Cicatrix Completed Phase 1 Trials for Kynurenic Acid (DB11937)

IndicationStatusPhase
DBCOND0036402 (Cicatrix)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02340325FS2 Safety and Tolerability Study in Healthy VolunteersTreatment